Home › Sezary Syndrome › Pennsylvania
Sezary Syndrome clinical trials in Pennsylvania
6 studies for Sezary Syndrome are looking for participants at sites in Pennsylvania.
Cities in Pennsylvania
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
- University of Pittsburgh Medical Center, Pittsburgh
RecruitingObservational study
Ages 18 and older · All sexes · Updated Nov 6, 2026 · NCT00177268Extracorporeal Photopheresis in Sezary Syndrome
- University of Pittsburgh Medical Center, Pittsburgh
RecruitingObservational study
Ages 18 to 100 · All sexes · Updated Nov 5, 2026 · NCT05157581A Prospective, US-based Study Assessing Mogamulizumab-associated Rash in Patients Diagnosed With Mycosis Fungoides or Sezary Syndrome and Treated With Standard of Care Mogamulizumab
- Thomas Jefferson University Hospital, Philadelphia
RecruitingObservational study
Ages 18 and older · All sexes · Updated Nov 4, 2026 · NCT07003100Phase 1 Trial of ST-001 nanoFenretinide in Relapsed/Refractory T-cell Non-Hodgkin Lymphoma
- University of Pittsburgh Medical Center (UPMC), Pittsburgh
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Oct 5, 2026 · NCT04234048A First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin Lymphoma
- University of Pennsylvania - Abramson Cancer Center, Philadelphia
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 30, 2026 · NCT07192471A Registry for People With T-cell Lymphoma
- University of Pennsylvania (Data Collection Only), Philadelphia
- Thomas Jefferson University Hospital (Data collection only), Philadelphia
RecruitingObservational study
All ages · All sexes · Updated May 20, 2026 · NCT05978141From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.